A61K 38/2292
Thymosin
Official title: {Thymosin; Related peptides}
A61K38/2292 (Thymosin) appears on 104 US grants and 190 published applications in this corpus.
Search patents in A61K- Granted patents
- 104
- Published applications
- 190
- Assignees
- 89
- Inventors
- 259
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 5 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 1 |
| 2002 | 2 | 1 |
| 2003 | 0 | 5 |
| 2004 | 0 | 7 |
| 2005 | 0 | 4 |
| 2006 | 1 | 10 |
| 2007 | 2 | 12 |
| 2008 | 1 | 8 |
| 2009 | 2 | 15 |
| 2010 | 3 | 14 |
| 2011 | 6 | 8 |
| 2012 | 10 | 9 |
| 2013 | 5 | 11 |
| 2014 | 4 | 6 |
| 2015 | 5 | 8 |
| 2016 | 4 | 11 |
| 2017 | 10 | 8 |
| 2018 | 6 | 9 |
| 2019 | 6 | 6 |
| 2020 | 3 | 8 |
| 2021 | 4 | 7 |
| 2022 | 2 | 4 |
| 2023 | 3 | 9 |
| 2024 | 3 | 2 |
| 2025 | 0 | 3 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-tumor pharmaceutical composition based on immune checkpoint blockade and use thereof14 Apr 2026US 12,599,596 B2Shanghai Hui Tian Jin Ze Biotech Co., Ltd.
- Treatment of cancer with immune stimulators10 Mar 2026US 12,569,542 B2Sciclone Pharmaceuticals International (Sg) Pte. Ltd.
- Thymosin alpha 1 for use in treatment of cystic fibrosis10 Sep 2024US 12,083,165 B2Sciclone Pharmaceuticals International (Sg) Pte. Ltd.
- Muscle cell patches and uses therefor14 May 2024US 11,980,698 B2Arizona Board of Regents on Behalf of the University of Arizona
- Enhancing chemotherapy in medulloblastoma and glioblastoma with high basal p53 levels13 Feb 2024US 11,896,650 B2Georgetown University
- Combination treatments to promote epithelial integrity and treat ocular disorders1 Oct 2026US 2026/0295013 A1Wayne State University
- Treatment of cancer with immune stimulators6 Aug 2026US 2026/0224667 A1Sciclone Pharmaceuticals International (Sg) Pte. Ltd.
- Biocompatible Material14 May 2026US 2026/0131045 A1
- Peptide compositions for treating hair loss30 Apr 2026US 2026/0115258 A1Restore Biologics Holdings, LLC
- Methods and compositions for detoxification of chronic exposure to toxins11 Sep 2025US 2025/0281531 A1
Most cited
By later US patents
- Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase160US 7,105,499 B2Isis Pharmaceuticals, Inc. · 2006
- Treatment of leg ulcers using placenta derived collagen biofabric79US 7,928,280 B2Anthrogenesis Corporation · 2011
- Therapeutic furopyrimidines and thienopyrimidines78US 7,429,571 B2BioCryst Pharmaceuticals, Inc. · 2008
- Hepatitis C therapies75US 7,514,410 B2BioCryst Pharmaceuticals, Inc. · 2009
- Composition and method of treating hepatitis C72US 5,849,696 ABoard of Governors of Wayne State University · 1998